People assigned female at birth have a predisposition for migraines, especially in adolescence and around menopause. Find a list of causes here.

The following is a summary of “Effectiveness and safety of anti-CGRP monoclonal antibodies for migraine in patients over 65 ...

Goadsby’s work showed that CGRP is a key factor in sensitizing these nociceptors. Clinical trials of drugs that block the peptide in people with migraine proved effective both in alleviating ...

Migraine disrupts daily life with invisible neurological pain, causing physical, emotional, and cognitive struggles that go ...

The NICE recommendation of Vyepti as a comparator to other treatments in the CGRP inhibitor class provides another option for people living with episodic or chronic migraine, particularly those ...

Any changes in routine-time changes, travel, earlier wake up times, can trigger a migraine. People who suffer with migraine ...

Data from the Phase III EMERGE trial show treatment with Symbravo provided more rapid and sustained migraine relief with improved quality of life in patients who previously had an inadequate response ...

Pfizer’s Vydura has become the first oral CGRP antagonist recommended for routine use by the NHS to prevent episodic migraine attacks, after being rejected earlier this year as an acute treatment.

Based on this discovery, the CGRP inhibitor 'Gepant' and several monoclonal antibodies have begun to be used to treat migraines. 'Migraine patients who receive Gepant are literally moved to tears ...

Atogepant vs placebo for the preventative treatment of migraine alleviated migraine symptoms across 3 clinical trials on day 1.

Symbravo demonstrated statistically significantly greater migraine treatment response than oral CGRP inhibitors, as measured by the Migraine Treatment Optimization Questionnaire (mTOQ-4 ...

Migraine is much more than just a headache ... such as calcitonin gene-related peptide (CGRP) pathway inhibitors and other innovative therapies, it is now possible to move beyond simply reducing ...